» Articles » PMID: 33209688

Diagnostic Value of Urinary Exosomal MiR-23b-3p, MiR-30a-5p, and MiR-151-3p in Children with Primary Nephrotic Syndrome

Overview
Date 2020 Nov 19
PMID 33209688
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Primary nephrotic syndrome (NS) is a common disease of the urinary system with an unclear pathogenesis. We aimed to detect the levels of urinary exosomal miR-23b-3p, miR-30a-5p, and miR-151-3p in children with primary NS, and to explore their diagnostic value for NS.

Methods: A total of 115 patients with NS who were admitted to the hospital from June 2017 to June 2019 were selected as the observation group. According to the disease progression, they were divided into an active group (acute active phase, n=68) and remission group (remission phase, n=47). In all, 50 healthy children were selected as the control group. Levels of urinary exosomal miR-23b-3p, miR-30a-5p, and miR-151-3p of each group in different periods were detected.

Results: The 24-h urine protein, serum albumin (ALB), and serum total cholesterol (TC) levels were significantly higher in the observation group than in the control group (P<0.05), while those in the active group were significantly higher than those in the remission group (P<0.05). The levels of miR-23b-3p and miR-30a-5p were significantly higher in the observation group than in the control group, and significantly higher in the active group than in the remission group (P<0.05). No miR-151-3p was detected in the urinary exosomes of the two groups. After treatment, levels of exosomal miR-23b-3p and miR-30a-5p in the two groups both decreased significantly (P<0.05). Results of receiver operating curve (ROC) curve analysis showed that urinary exosomal miR-23b-3p and miR-30a-5p can be used to identify children with NS and healthy children. The area under the ROC curve (AUC) was 0.711 for miR-23b-3p and 0.844 for miR-30a-5p.

Conclusions: The levels of miR-23b-3p and miR-30a-5p in urinary exosomes of children with NS were significantly higher than those in healthy children, and decreased significantly after treatment, indicating that miR-23b-3p and miR-30a-5p in urinary exosomes are potential indicators for diagnosing the progression of NS and monitoring the treatment effect.

Citing Articles

Panel miRNAs are potential diagnostic markers for chronic kidney diseases: a systematic review and meta-analysis.

Garmaa G, Nagy R, Koi T, Do To U, Gergo D, Kleiner D BMC Nephrol. 2024; 25(1):261.

PMID: 39138396 PMC: 11323638. DOI: 10.1186/s12882-024-03702-y.


Exosomal miR-30a-5p promoted intrahepatic cholangiocarcinoma progression by increasing angiogenesis and vascular permeability in PDCD10 dependent manner.

Jiang W, Shi X, Sun L, Zhang Y, Kong X, Yang X Int J Biol Sci. 2023; 19(14):4571-4587.

PMID: 37781039 PMC: 10535699. DOI: 10.7150/ijbs.83170.


Epigenetic Mechanisms and Nephrotic Syndrome: A Systematic Review.

Hayward S, Parmesar K, Welsh G, Suderman M, Saleem M Biomedicines. 2023; 11(2).

PMID: 36831050 PMC: 9953384. DOI: 10.3390/biomedicines11020514.


Infant Saliva Levels of microRNA miR-151a-3p Are Associated with Risk for Neurodevelopmental Delay.

Hicks S, Confair A Int J Mol Sci. 2023; 24(2).

PMID: 36674994 PMC: 9867475. DOI: 10.3390/ijms24021476.


Promotor Hypomethylation Mediated Upregulation of miR-23b-3p Targets PTEN to Promote Bronchial Epithelial-Mesenchymal Transition in Chronic Asthma.

Guo Y, Yuan X, Hong L, Wang Q, Liu S, Li Z Front Immunol. 2022; 12:771216.

PMID: 35058921 PMC: 8765721. DOI: 10.3389/fimmu.2021.771216.

References
1.
McCloskey O, Maxwell A . Diagnosis and management of nephrotic syndrome. Practitioner. 2017; 261(1801):11-5. View

2.
Luo Y, Wang C, Chen X, Zhong T, Cai X, Chen S . Increased serum and urinary microRNAs in children with idiopathic nephrotic syndrome. Clin Chem. 2013; 59(4):658-66. DOI: 10.1373/clinchem.2012.195297. View

3.
Xia X, Wang Y, Huang Y, Zhang H, Lu H, Zheng J . Exosomal miRNAs in central nervous system diseases: biomarkers, pathological mediators, protective factors and therapeutic agents. Prog Neurobiol. 2019; 183:101694. PMC: 7323939. DOI: 10.1016/j.pneurobio.2019.101694. View

4.
Tang Y, Yan W, Sun L, Huang J, Qian W, Ding Y . Prediction of intravenous immunoglobulin resistance in Kawasaki disease in an East China population. Clin Rheumatol. 2016; 35(11):2771-2776. DOI: 10.1007/s10067-016-3370-2. View

5.
Ho J, Ng K, Rosen S, Dostal A, Gregory R, Kreidberg J . Podocyte-specific loss of functional microRNAs leads to rapid glomerular and tubular injury. J Am Soc Nephrol. 2008; 19(11):2069-75. PMC: 2573018. DOI: 10.1681/ASN.2008020162. View